BRUNELLI, Matteo
 Distribuzione geografica
Continente #
NA - Nord America 16.756
EU - Europa 14.292
AS - Asia 10.591
SA - Sud America 1.667
AF - Africa 210
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 14
Totale 43.563
Nazione #
US - Stati Uniti d'America 16.328
GB - Regno Unito 4.279
CN - Cina 4.088
SG - Singapore 3.783
IT - Italia 2.321
BR - Brasile 1.452
HK - Hong Kong 1.387
SE - Svezia 1.378
DE - Germania 1.339
RU - Federazione Russa 1.146
IE - Irlanda 1.089
FR - Francia 1.035
FI - Finlandia 815
KR - Corea 345
CA - Canada 320
VN - Vietnam 268
UA - Ucraina 221
NL - Olanda 186
JP - Giappone 132
TR - Turchia 115
BE - Belgio 112
IN - India 73
AR - Argentina 68
AT - Austria 64
ES - Italia 62
TG - Togo 60
MX - Messico 57
BD - Bangladesh 54
PL - Polonia 54
ID - Indonesia 51
EC - Ecuador 46
IQ - Iraq 44
ZA - Sudafrica 41
LT - Lituania 36
CZ - Repubblica Ceca 28
MA - Marocco 28
AU - Australia 27
PK - Pakistan 26
CO - Colombia 25
IR - Iran 23
UZ - Uzbekistan 21
VE - Venezuela 20
AE - Emirati Arabi Uniti 18
EG - Egitto 18
KE - Kenya 18
PY - Paraguay 18
CL - Cile 17
AZ - Azerbaigian 16
LV - Lettonia 15
CH - Svizzera 14
SA - Arabia Saudita 14
JO - Giordania 13
IL - Israele 12
TN - Tunisia 12
HU - Ungheria 10
PH - Filippine 10
BG - Bulgaria 9
JM - Giamaica 9
MY - Malesia 9
NP - Nepal 9
PE - Perù 9
AM - Armenia 8
EU - Europa 8
GR - Grecia 8
KG - Kirghizistan 8
LK - Sri Lanka 8
PT - Portogallo 8
TW - Taiwan 8
AL - Albania 7
DK - Danimarca 7
DO - Repubblica Dominicana 7
HN - Honduras 7
PA - Panama 7
PS - Palestinian Territory 7
IM - Isola di Man 6
KZ - Kazakistan 6
LA - Repubblica Popolare Democratica del Laos 6
RO - Romania 6
BO - Bolivia 5
CI - Costa d'Avorio 5
DZ - Algeria 5
EE - Estonia 5
UY - Uruguay 5
CR - Costa Rica 4
HR - Croazia 4
LB - Libano 4
MK - Macedonia 4
NZ - Nuova Zelanda 4
RS - Serbia 4
SN - Senegal 4
TH - Thailandia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BY - Bielorussia 3
CM - Camerun 3
GE - Georgia 3
MD - Moldavia 3
MT - Malta 3
NO - Norvegia 3
OM - Oman 3
SV - El Salvador 3
Totale 43.503
Città #
Southend 3.738
Chandler 2.472
Dallas 2.102
Singapore 1.739
Hong Kong 1.374
Jacksonville 1.331
Dublin 1.076
Woodbridge 1.067
Ann Arbor 960
Ashburn 904
Beijing 803
Munich 486
Houston 449
New York 403
Verona 385
Lawrence 367
Princeton 367
Wilmington 345
Jinan 330
Los Angeles 297
Helsinki 284
Nanjing 247
The Dalles 241
Shenyang 229
Montréal 195
Mcallen 179
Columbus 176
Hebei 175
Milan 169
Buffalo 162
Redondo Beach 158
Rome 150
Tianjin 142
Sindelfingen 134
Turku 133
Dearborn 131
Zhengzhou 125
São Paulo 121
Tokyo 119
Redmond 118
Santa Clara 117
Seoul 109
Brussels 107
Ningbo 106
Seattle 104
Changsha 103
Taizhou 94
Bologna 92
Boardman 91
Guangzhou 89
Haikou 88
Nanchang 79
Frankfurt am Main 75
Redwood City 74
Taiyuan 70
Hangzhou 69
Lancaster 66
Jiaxing 65
San Francisco 64
Ho Chi Minh City 61
Lomé 60
Dong Ket 57
Brooklyn 56
Norwalk 52
Chicago 49
Volga 47
Rio de Janeiro 46
Moscow 45
Nuremberg 45
Toronto 43
Belo Horizonte 42
Fairfield 39
London 38
Amsterdam 37
Jakarta 37
Lanzhou 37
Vienna 37
Washington 37
Stockholm 36
Kent 35
Warsaw 35
Detroit 33
Hanoi 33
Mexico City 33
Fuzhou 32
Shanghai 31
Madrid 30
Boston 29
Brasília 29
Falls Church 29
Council Bluffs 28
Düsseldorf 28
Phoenix 28
Johannesburg 25
Atlanta 24
Montreal 24
Bari 22
Dongguan 22
Augusta 21
Chennai 21
Totale 27.538
Nome #
ARFI Evaluation of Small (<4 cm) Renal Masses. A Preliminary Study 846
I tumori ibridi nell'oncocitosi renale sono l'anello di congiunzione tra oncocitoma renale e il carcinoma renale di tipo cromofobo? 599
Instabilità dei microsatelliti nei carcinomi duttali e nei tumori endocrini del pancreas 316
A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapse. 243
A clinical-biological risk stratification model for resected gastric cancer: prognostic impact of Her2, Fhit, and APC expression status 218
Schwannoma del rene 202
Analisi citogenetica in metafase ed interfase nel carcinoma renale cromofobo e nell'onocitoma del rene 196
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 183
True 3q Chromosomal Amplification in Squamous Cell Lung Carcinoma by FISH and aCGH Molecular Analysis: Impact on Targeted Drugs 181
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 178
Breast cancer with both assessment of Her2/Neu overexpression and gene amplification:clinical impact in selecting patients for drug treatment 176
ALK gene copy number in lung cancer: Unspecific polyploidy versus specific amplification visible as double minutes 175
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 170
LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs 169
The 2012 Briganti nomogram predicts disease progression in surgically treated intermediate-risk prostate cancer patients with favorable tumor grade group eventually associated with some adverse factors 163
iPathology cockpit diagnostic station: validation according to College of American Pathologists Pathology and Laboratory Quality Center recommendation at the Hospital Trust and University of Verona 162
2012 Briganti nomogram predict prostate cancer progression in EAU intermediate risk with unfavorable tumor grade: A single center experience 161
Clinical Factors Predicting and Stratifying the Risk of Lymph Node Invasion in Localized Prostate Cancer 161
ALK/EML4 Fusion Gene May Be Found in Pure Squamous Carcinoma of the Lung 161
An unusual case of Cushing's syndrome due to ACTH-independent macronodular adrenal hyperplasia 158
Una complessa valutazione della vitalità delle fratture in ambito forense 156
Adrenal extramedullary hematopoiesis: report on a pediatric case and update of the literature. 155
Utilità diagnostica della valutazione della ploidia con citometria a flusso nella diagnosi differenziale delle neoplasie a cellule renali 155
ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations 155
8C.05: EPOXYEICOSATRIENOIC ACIDS ARE INCREASED IN PLACENTAS OF PREECLAMPTIC PREGNANCIES 154
Carcinoma a cellule renali associato ad evidente proliferazione stromale leiomiomatosa 152
Low-Risk Prostate Cancer and Tumor Upgrading to Higher Patterns in the Surgical Specimen. Analysis of Clinical Factors Predicting Tumor Upgrading to Higher Gleason Patterns in a Contemporary Series of Patients Who Have Been Evaluated According to the Modified Gleason Score Grading System 152
CD10 is expressed in a subset of chromophobe renal cell carcinomas 151
Carcinomi con traslocazioni coinvolgenti i geni della famiglia MiTF/TFE. 148
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 148
Adenocarcinoma of the paraurethral glands: a case report 146
Digital reporting of whole-slide images is safe and suitable for assessing organ quality in preimplantation renal biopsies 146
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 146
Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo" 145
Chondroid syringoma with extensive ossification 145
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes 144
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 144
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 143
Fast Chromotrope Aniline Blue Special Stain Is a Useful Tool to Assess Fibrosis on Liver Biopsy During Transplantation 143
L'ESPRESSIONE DI CITOCHERATINE E' IN ACCORDO CON LA DIFFERENZIAZIONE EPITELIALE DELLE NEOPLASIE RENALI HMB45 POSITIVE CON TRASLOCAZIONE T(6;11) 142
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers 142
Adult primary teratoma of the testis--report on 5 cases in clinical stage I disease. 141
Impact of neoadjuvant single or dual HER2 inhibition and chemotherapy backbone upon pathological complete response in operable and locally advanced breast cancer: Sensitivity analysis of randomized trials 141
The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy 140
Prostate Volume Index Associates with a Decreased Risk of Prostate Cancer: Results of a Large Cohort of Patients Elected to a First Biopsy Set 139
A Novel Prognostic Score based on Serum Alpha-Fetoprotein, Number of Nodules, and MYC Gene Status Predicts Prognosis of Patients after Liver Resection for Hepatocellular Carcinoma 139
Preoperative plasma levels of total testosterone associated with high grade pathology-detected prostate cancer: preliminary results of a prospective study in a contemporary cohort of patients 139
The identification of a small but significant subset of patients still targetable with anti-HER2 inhibitors when affected by triple negative breast carcinoma 139
Subepithelial haematoma of the renal pelvis (Antopol-Goldman lesion) 137
Clinical Factors of Disease Reclassification or Progression in a Contemporary Cohort of Prostate Cancer Patients Elected to Active Surveillance 137
Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: a systematic review and meta-analysis 137
The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies 137
De Novo Renal Neoplasia After Kidney Transplantation According to New 2016 WHO Classification of Renal Tumors 137
A distinctive translocation carcinoma of the kidney; "rosette forming," t(6;11), HMB45-positive renal tumor: a histomorphologic, immunohistochemical, ultrastructural, and molecular genetic study of 4 cases 136
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma. 136
Donor kidneys with miliary papillary renal cell neoplasia: the role of the pathologist in determining suitability for transplantation 136
Addressing the best treatment for non-clear cell renal cell carcinoma: A meta-analysis of randomised clinical trials comparing VEGFR-TKis versus mTORi-targeted therapies 136
Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage 'pure' and 'mixed' lobular breast cancer 135
Cathepsin-k as a diagnostic marker in the identification of micro-granulomas in Crohn's disease 135
A pseudotumoral lesion diagnosed for a hypertrofic fibrosis at the proximal stump in anterior tibialis tendon missed rupture: a case report 134
Bilateral lymph node micrometastases and seminal vesicle invasion associated with same clinical predictors in localized prostate cancer 134
Consultation between forensic and clinical pathologists for histopathology examination after forensic autopsy 134
Carcinoma a cellule renali di tipo papillare a cellule oncocitiche: studio clinico-patologico di 10 casi. 133
Neoadjuvant strategies for triple negative breast cancer: 'state-of-the-art' and future perspectives 133
Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Heat Shock Protein 90 Overexpression, Ki67 Proliferative Index, and Topoisomerase II-α Co-amplification as Predictors of Pathologic Complete Response to Neoadjuvant Chemotherapy With Trastuzumab and Docetaxel 133
Oncocytic papillary renal cell carcinoma: potential pitfall in small enucleation. 132
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 132
The Tumor Entity Denominated "clear cell-papillary renal cell carcinoma" According to the WHO 2016 new Classification, have the Clinical Characters of a Renal Cell Adenoma as does Harbor a Benign Outcome 132
Utilità diagnostica di CD13 e CD10 nelle neoplasie a cellule renali 131
CARCINOMI DELLA MAMMELLA POSITIVI ALL'IMMUNOESPRESSIONE PER HER-2: VALUTAZIONE CON METODICA FISH DEI CASI CON IMMUNOESPRESSIONE INTRATUMORALE ETEROGENEA 130
Molecular heterogeneity assessment by next-generation sequencing and response to gefitinib of EGFR mutant advanced lung adenocarcinoma 130
Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer 130
Clinical factors stratifying the risk of tumor upgrading to high-grade disease in low-risk prostate cancer 130
Ependymoma with diffuse signet-ring features: report of a case and review of the literature 130
Mesothelial/monocytic incidental cardiac excrescences (MICE): report of a case and review of literature with focus on pathogenesis 130
Adjuvant Chemotherapy For Resected Non-Small-Cell Lung Cancer: Future Perspectives For Clinical Research 130
Carcinoma renale a cellule chiare papillare: una distinta entità istopatologica e genetica 129
Association between Basal Total Testosterone Levels and Tumor Upgrading in Low and Intermediate Risk Prostate Cancer 129
Associations of Transitional Zone Volume with Intraprostatic Chronic Inflammation and Prostate Cancer Risk in Patients Undergoing a First Random Biopsy Set 129
Her-2/neu evaluation in Sister Mary Joseph's nodule from breast carcinoma: a case report and review of the literature 128
Genotypic Intratumoral Heterogeneity in Breast Carcinoma with HER2/neu Amplification Evaluation According to ASCO/CAP Criteria 127
HER2/neu Gene Determination in Women Screened for Breast Carcinoma: How Screening Programs Reduce the Skyrocketing Cost of Targeted Therapy 127
Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors 127
Targeting Met and VEGFR Axis in Metastatic Castration-Resistant Prostate Cancer: 'Game Over'? 127
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 126
Reprofiling Metastatic Samples for Chromosome 9p and 14q Aberrations as a Strategy to Overcome Tumor Heterogeneity in Clear-cell Renal Cell Carcinoma 126
Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder 126
Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 338 patients with conventional renal cell carcinoma 125
Pediatric optic nerve sheath meningioma 125
Autophagy pathways in drug abusers after forensic autopsy: LC3B, ph-mTOR and p70S6K analysis 125
Carcinomi della mammella con valutazione dello stato di Her-2 mediante immunoistochimica ed ibridazione in situ fluorescente: impatto clinico nella selezione dei pazienti per la terapia con Herceptin 124
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 124
ABO blood group system and risk of positive surgical margins in patients treated with robot-assisted radical prostatectomy: results in 1114 consecutive patients 124
[Diagnostic and prognostic markers in renal tumors] 123
Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma 123
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements 123
Immune Checkpoint Inhibitors and Prostate Cancer: A New Frontier? 122
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice 122
Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta 122
Consultation interface between Pathologist and Forensic Science Experts for histopathology examination 122
Totale 15.650
Categoria #
all - tutte 176.685
article - articoli 160.393
book - libri 0
conference - conferenze 15.968
curatela - curatele 0
other - altro 324
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 353.370


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.544 0 0 0 540 534 355 105 150 124 62 416 258
2021/20223.076 333 739 51 338 150 132 50 208 93 85 232 665
2022/20237.040 459 772 615 1.188 606 1.737 72 482 765 72 162 110
2023/20244.081 172 300 332 447 481 669 199 246 67 279 638 251
2024/202510.130 507 544 549 1.656 428 351 579 448 1.428 687 983 1.970
2025/20266.267 2.061 1.614 2.351 241 0 0 0 0 0 0 0 0
Totale 44.472